ABIVAX Société Anonyme (0RA9.L)

EUR 7.35

(-0.34%)

Operating Income Summary of ABIVAX Société Anonyme

ABIVAX Société Anonyme's latest annual operating income in 2023 was -127.37 Million EUR , down -133.02% from previous year.
ABIVAX Société Anonyme's latest quarterly operating income in 2024 Q2 was -79.99 Million EUR , down 0.0% from previous quarter.
ABIVAX Société Anonyme reported an annual operating income of -56.64 Million EUR in 2022, down -8.54% from previous year.
ABIVAX Société Anonyme reported an annual operating income of -52.18 Million EUR in 2021, down -31.8% from previous year.
ABIVAX Société Anonyme reported a quarterly operating income of -39.53 Million EUR for 2023 Q2, down 0.0% from previous quarter.
ABIVAX Société Anonyme reported a quarterly operating income of -90.17 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of ABIVAX Société Anonyme (2023 - 2013)

Historical Annual Operating Income of ABIVAX Société Anonyme (2023 - 2013)

Year	Operating Income	Operating Income Growth
2023	-127.37 Million EUR	-133.02%
2022	-56.64 Million EUR	-8.54%
2021	-52.18 Million EUR	-31.8%
2020	-39.59 Million EUR	-18.99%
2019	-33.27 Million EUR	-74.13%
2018	-19.1 Million EUR	-35.05%
2017	-14.15 Million EUR	22.41%
2016	-18.23 Million EUR	0.1%
2015	-18.25 Million EUR	-106.11%
2014	-8.85 Million EUR	-19.73%
2013	-7.39 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-79.99 Million EUR	0.0%
2023 Q2	-39.53 Million EUR	0.0%
2023 Q4	-90.17 Million EUR	0.0%
2023 FY	-131.99 Million EUR	-133.02%
2022 Q4	-38.02 Million EUR	0.0%
2022 FY	-56.64 Million EUR	-8.54%
2022 Q2	-18.62 Million EUR	0.0%
2021 FY	-52.18 Million EUR	-31.8%
2021 Q4	-25.68 Million EUR	0.0%
2021 Q2	-26.53 Million EUR	0.0%
2020 Q4	-23.38 Million EUR	0.0%
2020 Q2	-16.21 Million EUR	0.0%
2020 FY	-39.59 Million EUR	-18.99%
2019 Q2	-17.2 Million EUR	0.0%
2019 FY	-33.27 Million EUR	-74.13%
2019 Q4	-16.06 Million EUR	0.0%
2018 Q4	-10.54 Million EUR	0.0%
2018 FY	-19.1 Million EUR	-35.05%
2018 Q2	-8.56 Million EUR	0.0%
2017 Q2	-7.4 Million EUR	0.0%
2017 FY	-14.15 Million EUR	22.41%
2017 Q4	-6.74 Million EUR	0.0%
2016 Q4	-7.61 Million EUR	0.0%
2016 Q2	-10.61 Million EUR	0.0%
2016 FY	-18.23 Million EUR	0.1%
2015 FY	-18.25 Million EUR	-106.11%
2015 Q4	-10.14 Million EUR	0.0%
2015 Q2	-8.1 Million EUR	0.0%
2014 Q4	-4.29 Million EUR	-199900.0%
2014 Q2	-757 Thousand EUR	-199900.0%
2014 Q1	-378.50 EUR	0.0%
2014 FY	-8.85 Million EUR	-19.73%
2014 Q3	-2148.50 EUR	99.72%
2013 FY	-7.39 Million EUR	0.0%

Peer Operating Income Comparison of ABIVAX Société Anonyme

Name	Operating Income	Operating Income Difference
Boiron SA	42.29 Million EUR	401.197%
Laboratorios Farmaceuticos Rovi, S.A.	220.25 Million EUR	157.831%
Vetoquinol SA	74.26 Million EUR	271.518%
Valneva SE	-82.08 Million EUR	-55.172%
AB Science S.A.	-13.42 Million EUR	-848.514%
Nanobiotix S.A.	-26.77 Million EUR	-375.656%
PHAXIAM Therapeutics S.A.	-23.66 Million EUR	-438.36%
Vivoryon Therapeutics N.V.	-28.83 Million EUR	-341.71%
BioSenic S.A.	-7.04 Million EUR	-1709.318%
Formycon AG	-369 Thousand EUR	-34419.241%